Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu

Safety and Efficacy of Repeated Administration of NurOwn (MSC-NTF Cells) in Participants With Progressive MS

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03799718
Recruitment Status : Not yet recruiting
First Posted : January 10, 2019
Last Update Posted : January 11, 2019
Sponsor:
Information provided by (Responsible Party):
Brainstorm-Cell Therapeutics

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Not yet recruiting
  Estimated Primary Completion Date : February 2020
  Estimated Study Completion Date : September 2020